Lenalidomide-Based vs Bortezomib-Based Induction in Patients With Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of Efficacy, Safety, Patients' Quality of Life, and Doctors' Occupational Stress Between Lenalidomide-Based and Bortezomib-Based Induction in Patients With Newly Diagnosed Multiple Myeloma
Cancer Med 2021 Feb 02;[EPub Ahead of Print], L Xu, J Liu, B Huang, L Kuang, J Gu, M Chen, W Zou, J LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.